Us Bancorp \De\ Beam Therapeutics Inc. Transaction History

Us Bancorp \De\

$82.9 Billion
Q3 2025

A detailed history of Us Bancorp \De\ transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 777 shares of BEAM stock, worth $17,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares

777

Previous 592 31.25%

Holding current value

$17,109

Previous $10,000 80.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$16.01 - $25.1 $2,961 - $4,643	185 Added 31.25%	777 $18,000
Q2 2025 Jul 23, 2025	SELL	$14.54 - $20.24 $930 - $1,295	-64 Reduced 9.76%	592 $10,000
Q1 2025 May 08, 2025	BUY	$19.53 - $34.09 $6,796 - $11,863	348 Added 112.99%	656 $12,000
Q4 2024 Feb 05, 2025	SELL	$21.55 - $30.35 $5,947 - $8,376	-276 Reduced 47.26%	308 $7,000
Q3 2024 Oct 28, 2024	SELL	$22.57 - $33.14 $37,263 - $54,714	-1,651 Reduced 73.87%	584 $14,000

Q2 2024 Aug 06, 2024	SELL	$21.22 - $32.66 $190 - $293	-9 Reduced 0.4%	2,235 $52,000
Q1 2024 May 07, 2024	BUY	$23.46 - $45.07 $5,325 - $10,230	227 Added 11.25%	2,244 $74,000
Q4 2023 Feb 09, 2024	SELL	$17.69 - $30.76 $123 - $215	-7 Reduced 0.35%	2,017 $54,000
Q3 2023 Nov 03, 2023	BUY	$23.01 - $32.46 $39,278 - $55,409	1,707 Added 538.49%	2,024 $48,000
Q2 2023 Aug 09, 2023	SELL	$29.32 - $35.99 $8,620 - $10,581	-294 Reduced 48.12%	317 $10,000
Q1 2023 May 09, 2023	BUY	$30.15 - $48.79 $5,698 - $9,221	189 Added 44.79%	611 $18,000
Q4 2022 Feb 13, 2023	SELL	$36.73 - $51.6 $230,921 - $324,409	-6,287 Reduced 93.71%	422 $16,000
Q3 2022 Oct 27, 2022	SELL	$39.79 - $70.31 $21,446 - $37,897	-539 Reduced 7.44%	6,709 $319,000
Q2 2022 Aug 01, 2022	SELL	$29.86 - $62.36 $106,122 - $221,627	-3,554 Reduced 32.9%	7,248 $282,000
Q1 2022 May 11, 2022	BUY	$53.73 - $82.16 $30,679 - $46,913	571 Added 5.58%	10,802 $619,000
Q4 2021 Feb 11, 2022	BUY	$68.02 - $99.06 $40,812 - $59,436	600 Added 6.23%	10,231 $815,000
Q3 2021 Nov 10, 2021	BUY	$84.37 - $133.6 $12,908 - $20,440	153 Added 1.61%	9,631 $839,000
Q2 2021 Aug 05, 2021	BUY	$64.12 - $128.71 $284,756 - $571,601	4,441 Added 88.17%	9,478 $1.22 Million
Q1 2021 Apr 28, 2021	BUY	$71.28 - $120.75 $287,757 - $487,467	4,037 Added 403.7%	5,037 $403,000
Q4 2020 Feb 04, 2021	SELL	$22.24 - $95.63 $44,480 - $191,260	-2,000 Reduced 66.67%	1,000 $82,000
Q3 2020 Nov 10, 2020	BUY	$19.0 - $30.57 $57,000 - $91,710	3,000 New	3,000 $74,000

Others Institutions Holding BEAM

# of Institutions

249

Shares Held

95M

Call Options Held

888K

Put Options Held

549K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account